IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q1 2023 Holdings

Filed 2023-05-12 | 11 holdings | $242.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Karuna Therapeutics IncCOM48576A100$142.0M782,00858.5%
Vaxcyte Inc(PCVX)COM92243G108$26.0M693,03910.7%
Inozyme Pharma IncCOM45790W108$18.4M3,213,5867.6%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$17.7M2,381,1967.3%
Rallybio CorpCOM75120L100$13.7M2,404,6445.7%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$6.3M569,0412.6%
Fusion Pharmaceuticals IncCOM36118A100$5.9M1,560,9822.4%
Vigil Neuroscience Inc(VIGL)COM92673K108$5.5M560,5952.3%
Exscientia PLCADS30223G102$4.1M772,2851.7%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$2.6M1,891,4671.1%
Aligos Therapeutics IncCOM01626L105$649.6K743,2150.3%